Xtant Medical Holdings Inc. Announces Election of Abhinav Jain and Tyler Lipschultz to Board of Directors

Reuters
Aug 04
<a href="https://laohu8.com/S/XTNT">Xtant Medical Holdings Inc</a>. Announces Election of Abhinav Jain and Tyler Lipschultz to Board of Directors

Xtant Medical Holdings Inc. has announced the election of Abhinav (Abi) Jain and Tyler Lipschultz to its Board of Directors, effective August 1, 2025. Mr. Jain will serve on the Compensation Committee and Nominating and Corporate Governance Committee, while Mr. Lipschultz will join the Audit Committee and Compensation Committee. Mr. Jain is currently an Analyst at Nantahala Capital Management, and Mr. Lipschultz brings experience from roles at companies like Spine Wave and Piper Jaffray.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xtant Medical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-022002), on August 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10